AU Stock MarketDetailed Quotes
OSLOB OncoSil Medical Ltd
- 0.005
- +0.001+25.00%
20min DelayMarket Closed Jul 19 16:00 AET
16.99MMarket Cap0.00P/E (Static)
0.005High0.004Low7.54MVolume0.004Open0.004Pre Close33.27KTurnover0.00552wk High0.26%Turnover Ratio3.40BShares0.00252wk Low--EPS TTM14.26MFloat Cap0.005Historical High0.00P/E (Static)2.85BShs Float0.002Historical Low--EPS LYR25.00%Amplitude--Dividend TTM0.00P/B1Lot Size--Div YieldTTM
OncoSil Medical Ltd Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | |
|---|---|---|---|---|
| Operating cash flow (direct method) | ||||
| Cash income from operating activities | 8.48%1.19M | -64.79%1.1M | -18.05%3.12M | 3.81M |
| Revenue from customers | 38.67%370.48K | 26.65%267.16K | --210.94K | ---- |
| Income from government grants | -1.22%821.48K | -71.42%831.6K | 3,169.07%2.91M | --89K |
| Other cash income from operating activities | ---- | ---- | ---- | --3.72M |
| Cash paid | -12.14%-12.56M | 6.69%-11.2M | -43.61%-12M | -8.36M |
| Payments to suppliers for goods and services | -12.14%-12.56M | 6.69%-11.2M | -43.61%-12M | ---8.36M |
| Direct interest paid | 44.46%-10.9K | -24.62%-19.62K | -42.06%-15.75K | ---11.09K |
| Direct interest received | 517.97%62.61K | -87.72%10.13K | -21.36%82.48K | --104.88K |
| Operating cash flow | -11.92%-11.32M | -14.69%-10.11M | -97.83%-8.82M | ---4.46M |
| Investing cash flow | ||||
| Cash flow from continuing investing activities | -891.41%-57.82K | 89.20%-5.83K | -160.61%-54K | -20.72K |
| Net PPE purchase and sale | -891.41%-57.82K | 89.20%-5.83K | -160.61%-54K | ---20.72K |
| Cash from discontinued investing activities | ||||
| Investing cash flow | -891.41%-57.82K | 89.20%-5.83K | -160.61%-54K | ---20.72K |
| Financing cash flow | ||||
| Cash flow from continuing financing activities | 3.62%9.49M | 8,129.98%9.16M | -99.37%111.25K | 17.79M |
| Net issuance payments of debt | ---- | ---- | -200.00%-26.56K | --26.56K |
| Net common stock issuance | 3.85%9.67M | 3,483.17%9.32M | -98.55%260K | --17.88M |
| Net other financing activities | -16.84%-187.21K | -31.14%-160.23K | -0.90%-122.18K | ---121.1K |
| Cash from discontinued financing activities | ||||
| Financing cash flow | 3.62%9.49M | 8,129.98%9.16M | -99.37%111.25K | --17.79M |
| Net cash flow | ||||
| Beginning cash position | -7.84%11.28M | -41.71%12.24M | 173.08%21M | --7.69M |
| Current changes in cash | -96.46%-1.89M | 89.04%-960K | -165.81%-8.76M | --13.31M |
| End cash Position | -16.72%9.39M | -7.84%11.28M | -41.71%12.24M | --21M |
| Free cash from | -12.43%-11.37M | -14.06%-10.12M | -98.12%-8.87M | ---4.48M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
%Chg